- Home
- SQFT vs HOTH Comparison
SQFT vs HOTH Comparison
Compare SQFT & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQFT
- HOTH
- Stock Information
- Founded
- SQFT 1999
- HOTH 2017
- Country
- SQFT United States
- HOTH United States
- Employees
- SQFT N/A
- HOTH N/A
- Industry
- SQFT Real Estate Investment Trusts
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- SQFT Real Estate
- HOTH Health Care
- Exchange
- SQFT Nasdaq
- HOTH Nasdaq
- Market Cap
- SQFT 8.1M
- HOTH 8.3M
- IPO Year
- SQFT 2020
- HOTH 2019
- Fundamental
- Price
- SQFT $0.61
- HOTH $1.13
- Analyst Decision
- SQFT
- HOTH Strong Buy
- Analyst Count
- SQFT 0
- HOTH 4
- Target Price
- SQFT N/A
- HOTH $4.75
- AVG Volume (30 Days)
- SQFT 23.3K
- HOTH 1.1M
- Earning Date
- SQFT 03-18-2025
- HOTH 03-27-2025
- Dividend Yield
- SQFT N/A
- HOTH N/A
- EPS Growth
- SQFT N/A
- HOTH N/A
- EPS
- SQFT N/A
- HOTH N/A
- Revenue
- SQFT $18,586,052.00
- HOTH N/A
- Revenue This Year
- SQFT N/A
- HOTH N/A
- Revenue Next Year
- SQFT N/A
- HOTH N/A
- P/E Ratio
- SQFT N/A
- HOTH N/A
- Revenue Growth
- SQFT 5.44
- HOTH N/A
- 52 Week Low
- SQFT $0.47
- HOTH $0.58
- 52 Week High
- SQFT $1.39
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- SQFT 40.86
- HOTH 52.08
- Support Level
- SQFT $0.62
- HOTH $0.84
- Resistance Level
- SQFT $0.65
- HOTH $1.18
- Average True Range (ATR)
- SQFT 0.03
- HOTH 0.13
- MACD
- SQFT 0.00
- HOTH 0.02
- Stochastic Oscillator
- SQFT 14.29
- HOTH 64.44
About SQFT Presidio Property Trust Inc.
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.